Neurim Pharmaceuticals Ltd. is a drug discovery and development company. Circadin®, its first approved drug, is commercially available globally.
Mentions in press and media 3
| Date | Title | Description |
| 31.07.2024 | A Beacon of Hope: Neurim Pharmaceuticals' Slenyto® for Children with Neurogenetic Disorders | In a world where sleep is often taken for granted, a new light shines for children battling neurogenetic disorders. Neurim Pharmaceuticals has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the... |
| 30.07.2024 | NEURIM PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION ON SLENYTO® (PEDIATRIC PROLONGED-RELEASE MELATONIN) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH NEUROGENETIC DISORDERS (NGDs) | TEL-AVIV, Israel, July 30, 2024 /PRNewswire/ -- Neurim Pharmaceuticals ("Neurim") announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, reco... |
| 30.07.2024 | NEURIM PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION ON SLENYTO® (PEDIATRIC PROLONGED-RELEASE MELATONIN) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH NEUROGENETIC DISORDERS (NGDs) | TEL-AVIV, Israel , July 30, 2024 /PRNewswire/ -- Neurim Pharmaceuticals ("Neurim") announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, rec... |